Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The glycosylation of the circulating immunoglobulin-gamma (IgG) antibody molecules changes in rheumatoid arthritis. The extent of the changes correlates with the disease severity and reverses in remission. We demonstrate here that the alteration in glycosylation associated with rheumatoid arthritis can create a new mode for the interaction of IgG with complement through binding to the collagenous lectin mannose-binding protein (MBP). Rheumatoid arthritis is associated with a marked increases in IgG glycoforms that lack galactose (referred to as G0 glycoforms) in the Fc region of the molecule and that terminate in N-acetyl glucosamine (GlcNAc). We show, using nuclear magnetic resonance (NMR) and X-ray data, that these terminal GlcNAc residues become accessible for MBP binding. We further demonstrate that multiple presentation of IgG-G0 glycoforms to MBP results in activation of the complement. This suggests that a contribution to the chronic inflammation of the synovial membrane could arise from the localization of the IgG-G0 glycoforms in the affected joint and from resulting activation of complement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
Meiboom, S., & Gill, D. (1958) · Review of Scientific Instruments · doi:10.1063/1.1716296 · Cited by 6,022
The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
Porter, R. R. (1959) · Biochemical Journal · doi:10.1042/bj0730119 · Cited by 2,308
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Self-citationStructure of a C-type mannose-binding protein complexed with an oligosaccharide
Weis, W. I., Drickamer, K., & Hendrickson, W. A. (1992) · Nature · doi:10.1038/360127a0 · Cited by 885
The binding site for C1q on IgG
Duncan, A. R., & Winter, G. (1988) · Nature · doi:10.1038/332738a0 · Cited by 569
Drickamer, K., Dordal, M. S., & Reynolds, L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62698-0 · Cited by 429
Serum lectin with known structure activates complement through the classical pathway.
Ikeda, K., Sannoh, T., Kawasaki, N., Kawasaki, T., & Yamashina, I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47587-4 · Cited by 424
Trimeric structure of a C-type mannose-binding protein
Weis, W. I., & Drickamer, K. (1994) · Structure · doi:10.1016/s0969-2126(94)00124-3 · Cited by 307
Research works printed but not linked: 2
- Chang, S.-C. Altered Glycosylation in Immunoglobulin G and Its Fragments in Rheumatoid Arthritis. thesis, Oxford (1993).
- Parekh, R.B. A Study of the Structure and Biosynthesis of N-linked Oligosaccharides and of their Involvement in Certain Diseases. thesis, Oxford Univ.(1987).
Cited by
Items 301–400 of 844
Wu, L., Ficker, M., Christensen, J. B., Simberg, D., Trohopoulos, P. N., & Moghimi, S. M. (2021) · Nature Communications · doi:10.1038/s41467-021-24960-6 · Cited by 52
Holers, V. M., & Kulik, L. N. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.07.003 · Cited by 55
Interaction of Mannan Binding Lectin with α2 Macroglobulin via Exposed Oligomannose Glycans
Arnold, J. N., Wallis, R., Willis, A. C., Harvey, D. J., Royle, L., Dwek, R. A., Rudd, P. M., & Sim, R. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511432200 · Cited by 52
Self-citationSolomon, S., Kolb, C., Mohanty, S., Jeisy‐Walder, E., Preyer, R., Schöllhorn, V., & Illges, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<644::aid-immu644>3.0.co;2-5 · Cited by 52
The Role of Glycosylation in Autoimmune Disease
Delves, P. J. (1998) · Autoimmunity · doi:10.3109/08916939808993836 · Cited by 53
Protein Glycosylation: Implications for In Vivo Functions and Therapeutic Applications
Bhatia, P. K., & Mukhopadhyay, A. (1999) · Advances in biochemical engineering, biotechnology · doi:10.1007/3-540-49811-7_5 · Cited by 52
Zhou, H., Yan, H., Bertram, P. G., Hu, Y., Springer, L. E., Thompson, R. W., Curci, J. A., Hourcade, D. E., & Pham, C. T. N. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315512110 · Cited by 51
“The absence of terminal galactose residues exposes the high mannose core carbohydrate structure that becomes accessible to MBL (24).”
BackgroundPeerschke, E. I. B., Panicker, S., & Bussel, J. B. (2015) · British Journal of Haematology · doi:10.1111/bjh.13648 · Cited by 50
Intense Physical Exercise Induces an Anti-inflammatory Change in IgG N-Glycosylation Profile
Tijardović, M., Marijančević, D., Bok, D., Kifer, D., Lauc, G., Gornik, O., & Keser, T. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01522 · Cited by 50
“Glycans that lack terminal galactose activate complement and make IgG pro-inflammatory, while the addition of galactose decreases inflammatory potential of IgG (Malhotra et al., 1995; Karsten et al., 2012; Mihai and Nimmerjahn, 2013).”
BackgroundGalactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation
McDonald, A. G., Hayes, J. M., Bezak, T., Gluchowska, S. A., Cosgrave, E. F. J., Struwe, W. B., Stroop, C. J. M., Kok, H. J., van de Laar, T., Rudd, P. M., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.151878 · Cited by 49
“In addition, individual monosaccharide residues of IgG specify the particular immune response induced by IgG: for example, IgG lacking galactose (IgG G0) residues can interact with mannosebinding lectin (MBL) to activate complement (Malhotra et al., 1995); IgG galactosylation is increased in pregnant women and is invo…”
BackgroundSelf-citationLectin-based Immunoassay for Aberrant IgG Glycosylation as the Biomarker for Crohnʼs Disease
Shinzaki, S., Kuroki, E., Iijima, H., Tatsunaka, N., Ishii, M., Fujii, H., Kamada, Y., Kobayashi, T., Shibukawa, N., Inoue, T., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318280eade · Cited by 49
Kao, D., Lux, A., Schaffert, A., Lang, R., Altmann, F., & Nimmerjahn, F. (2017) · European Journal of Immunology · doi:10.1002/eji.201747208 · Cited by 50
Natural antibodies, autoantibodies and complement activation in tissue injury
Fleming, S. D. (2006) · Autoimmunity · doi:10.1080/08916930600739381 · Cited by 49
“evidence shows that a glycosylation altered IgG may activate the lectin pathway in rheumatoid arthritis patients [38].”
BackgroundDynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation
Voynov, V., Chennamsetty, N., Kayser, V., Helk, B., Forrer, K., Zhang, H., Fritsch, C., Heine, H., & Trout, B. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008425 · Cited by 42
“Moreover, increased surface exposure of GlcNAc in G0 glycovariants is associated with higher binding to mannosebinding protein (MBP) [29].”
BackgroundInfluentialHuang, Y., Wang, W., Han, J., Wu, X. W., Zhang, S., Liu, C. J., Hu, Q., Xiong, P., Hamvas, R. M. J., Wood, N., et al. (2003) · European Journal of Immunogenetics · doi:10.1046/j.1365-2370.2003.00370.x · Cited by 49
“As a member of the complement family, MBL has been shown to interact with hypoglycosylated immunoglobulin G (IgG) (Malhotra et al., 1995), which may represent a mechanism for its participation in the clearance of immune complex and strongly suggests that MBL deficiency may be associated with SLE (Davies et al.”
BackgroundMechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Tackenberg, B., Nimmerjahn, F., & Lünemann, J. D. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9398-1 · Cited by 48
“Notably, IgG-G0 glycoforms are markedly increased in patients with rheumatoid arthritis [34].”
BackgroundYu, B., HEISS, G. M., Alexander, D. C., Grams, M. E., & Boerwinkle, E. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv213 · Cited by 48
Huang, C., Liu, Y., Wu, H., Sun, D., & Li, Y. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0302-1 · Cited by 48
Zhang, D., Chen, B., Wang, Y., Xia, P., He, C., Liu, Y., Zhang, R., Zhang, M., & Li, Z. (2016) · Scientific Reports · doi:10.1038/srep25957 · Cited by 46
Comparability study of Rituximab originator and follow-on biopharmaceutical
Montacir, O., Montacir, H., Eravci, M., Springer, A., Hinderlich, S., Saadati, A., & Parr, M. K. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.03.029 · Cited by 47
Glycosylation of Natural and Recombinant Antibody Molecules
Jefferis, R. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-25515-x_26 · Cited by 47
“The terminal sugar residue of G0F glycoforms is N-acetylglucosamine; there is evidence that immune complexes incorporating this glycoform may bind and activate mannan-binding protein, with the activation of a pseudo-classical complement pathway, and cellular mannose receptor, facilitating uptake by dendritic cells [8…”
BackgroundBlondeel, E. J. M., & Aucoin, M. G. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.06.008 · Cited by 46
The role of antibody glycosylation in autoimmune and alloimmune kidney diseases
Beyze, A., Larroque, C., & Quintrec, M. L. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00850-0 · Cited by 45
“Remarkably, a substantial increase in MBL binding occurred when the level of agalactosylation of IgG from healthy individuals was enzymatically raised from 20% to 100% 102 .”
InfluentialImmunoglobulin Glycosylation Effects in Allergy and Immunity
Epp, A., Locker, K. C. S., Herr, A. B., & Strait, R. T. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0658-x · Cited by 45
Sugimoto, M., Watanabe, H., Asano, T., Sato, S., Takagi, T. J., Kobayashi, H., & Ohira, H. (2015) · Modern Rheumatology · doi:10.3109/14397595.2015.1076924 · Cited by 44
“For example, in patients with rheumatoid arthritis, the serum levels of IgG lacking galactose are increased, and IgG with exposed terminal GlucNAc residues bind to MBL, resulting in the activation of MBLP [25].”
BackgroundGomes, M. M., Suzuki, H., Brooks, M. T., Tomana, M., Moldoveanu, Z., Mestecky, J. F., Julian, B. A., Novák, J., & Herr, A. B. (2010) · Biochemistry · doi:10.1021/bi9019498 · Cited by 44
Increased central adiposity is associated with pro-inflammatory immunoglobulin G N-glycans
Russell, A. C., Kępka, A., Trbojević‐Akmačić, I., Ugrina, I., Song, M., Hui, J., Hunter, M. L., Laws, S. M., Lauc, G., & Wang, W. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.10.002 · Cited by 44
Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance
Gupta, B., Raghav, S. K., Agrawal, C., Chaturvedi, V. P., Das, R. H., & Das, H. R. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.07.002 · Cited by 44
Collectin surfactant protein D binds antibodies and interlinks innate and adaptive immune systems
Nadesalingam, J., Reid, K. B. M., & Palaniyar, N. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.012 · Cited by 45
“Although native octadecameric SP-A does not interact with IgG [28], MBL can recognize aberrantly glycosylated forms of IgGs [29], oligomeric sIgA and IgA isolated from nephropathy patients via lectin carbohydrate interactions [30].”
BackgroundThe glycosylation pattern of a humanized IgGl antibody (D1.3) expressed in CHO cells
Routier, F. H., Davies, M. J., Bergemann, K., & Hounsell, E. F. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018589704981 · Cited by 44
The effect of TNF-α on glycosylation pathways in bovine synoviocytes
Yang, X., Lehotay, M., Anastassiades, T., Harrison, M., & Brockhausen, I. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-058 · Cited by 45
“There is also a correlation between specific glycosylation patterns in inflamed tissues and the resulting apoptotic susceptibility (Keppler et al. 1999; Hiraishi et al. 1993; Parekh et al. 1985; Malhotra et al. 1995; Delves 1998).”
BackgroundRapid LC–MS screening for IgG Fc modifications and allelic variants in blood
Goetze, A. M., Zhang, Z., Liu, L., Jacobsen, F. W., & Flynn, G. C. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.09.002 · Cited by 43
Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer
Wieczorek, M., Braicu, E. I., Oliveira‐Ferrer, L., Sehouli, J., & Blanchard, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00654 · Cited by 43
“alternative pathway (33, 34) and the lectin pathway, after binding to mannose-binding lectin (19, 35).”
BackgroundIgG N-glycome changes during the course of severe COVID-19: An observational study
Petrović, T., Vijay, A., Vučković, F., Trbojević‐Akmačić, I., Ollivere, B. J., Marjanović, D., Bego, T., Prnjavorac, B., Đerek, L., Markotić, A., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104101 · Cited by 44
“34 Table 3 : Statistical analysis of IgG glycome composition changes during severe and mild COVID-19.”
Unravelling Glycobiology by NMR Spectroscopy
Vitor, H. (2012) · InTech eBooks · doi:10.5772/48136 · Cited by 43
“Some of the key glycan-mediated interactions with receptors, for example, are indicated and properly referenced [20-24].”
IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease
Xue, J., Zhu, L.-P., & Wei, Q. (2013) · Glycoconjugate Journal · doi:10.1007/s10719-013-9481-y · Cited by 43
Carbohydrate biomarkers for future disease detection and treatment
Cheng, Y., Li, M., Wang, S., Peng, H., Reid, S., Ni, N., Fang, H., Xu, W., & Wang, B. (2010) · Science China Chemistry · doi:10.1007/s11426-010-0021-3 · Cited by 43
Ray, T. D., Lewis, L. A., Gulati, S., Rice, P. A., & Ram, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003623 · Cited by 43
“However, terminal N-acetylglucosamine residues or IgG bearing high mannose residues may bind mannan-binding lectin, which in some instances could contribute to complement activation (74).”
BackgroundMitchell, D. A., Kirby, L., Paulin, S. M., VILLIERS, C. L., & Sim, R. B. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.12.027 · Cited by 43
Self-citationC4d in Native Glomerular Diseases
Chandra, P. (2019) · American Journal of Nephrology · doi:10.1159/000496059 · Cited by 42
Chen, G., Wang, Y., Qin, X., Li, H., Guo, Y., Wang, Y., Liu, H., Wang, X., Song, G., Li, F., et al. (2013) · Electrophoresis · doi:10.1002/elps.201200455 · Cited by 42
Salant, D. J. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020166 · Cited by 42
Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG
Rudman, N., Kifer, D., Kaur, S., Simunović, V., Cvetko, A., Pociot, F., Morahan, G., & Gornik, O. (2022) · Diabetologia · doi:10.1007/s00125-022-05703-8 · Cited by 41
Humoral signatures of MOG-antibody-associated disease track with age and disease activity
Spatola, M., Chuquisana, O., Jung, W., Lopez, J. A., Wendel, E., Ramanathan, S., Keller, C. W., Hahn, T., Meinl, E., Reindl, M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100913 · Cited by 41
Troelsen, L. N., Jacobsen, S., Abrahams, J. L., Royle, L., Rudd, P. M., Narvestad, E., Heegaard, N. H. H., & Garred, P. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110584 · Cited by 41
Self-citationMontacir, O., Montacir, H., Springer, A., Hinderlich, S., Mahboudi, F., Saadati, A., & Parr, M. K. (2018) · The Protein Journal · doi:10.1007/s10930-018-9757-y · Cited by 41
Constrained global sensitivity analysis for bioprocess design space identification
Kotidis, P., Demis, P., Goey, C. H., Correa, E., McIntosh, C., Trepekli, S., Shah, N., Klymenko, O. V., & Kontoravdi, C. (2019) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2019.01.022 · Cited by 40
Lardinois, O. M., Deterding, L. J., Hess, J. J., Poulton, C. J., Henderson, C. D., Jennette, J. C., Nachman, P. H., & Falk, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213215 · Cited by 40
An Inflammatory Story: Antibodies in Tuberculosis Comorbidities
McLean, M. R., Lu, L. L., Kent, S. J., & Chung, A. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02846 · Cited by 40
Lundström, S. L., Fernandes‐Cerqueira, C., Ytterberg, A. J., Ossipova, E., Hensvold, A. H., Jakobsson, P., Malmström, V., Catrina, A. I., Klareskog, L., Lundberg, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113924 · Cited by 41
The effect on IgG glycosylation of altering 1,4-galactosyltransferase-1 activity in B cells
Keusch, J. J., Lydyard, P. M., & Delves, P. (1998) · Glycobiology · doi:10.1093/glycob/8.12.1215 · Cited by 40
“…of the IgG molecule including binding to complement component C1q (Tsuchiya et al., 1989; Wright and Morrison, 1998), mannose-binding protein (Malhotra et al., 1995; Wright and Morrison, 1998), and, in some studies, FcγR (Tsuchiya et al., 1989; Cant et al., 1994; Kumpel et al., 1994),…”
BackgroundArthur, C. M., Chonat, S., Fasano, R. M., Yee, M. E. M., Josephson, C. D., Roback, J. D., & Stowell, S. R. (2019) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2019.09.006 · Cited by 40
“Distinct Fc glycoforms may not only affect binding to Fc receptors, but also impact binding to C1q and subsequent complement activation [29,30].”
BackgroundAssociation of the IgG N -glycome with the course of kidney function in type 2 diabetes
Singh, S. S., Heijmans, R., der Meulen, C. C. M. V. C.-V., Lieverse, A. G., Gornik, O., Sijbrands, E. J. G., Lauc, G., & van Hoek, M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001026 · Cited by 40
Cell surface expression of C1qRP/CD93 is stabilized by O‐glycosylation
Park, M., & Tenner, A. J. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10332 · Cited by 40
“…of mechanistically distinct disorders including autoimmune disorders (Parekh et al., 1985; Watson et al., 1999; Demetriou et al., 2001; Rudd et al., 2001), inflammatory disease (Parekh et al., 1985; Malhotra et al., 1995), and metabolic disorders (Feramisco et al., 1973; Niehues et al., 1998).”
BackgroundAmann, T., Hansen, A. H., Kol, S., Lee, G. M., Andersen, M. R., & Kildegaard, H. F. (2018) · Biotechnology Journal · doi:10.1002/biot.201800111 · Cited by 37
Lyse or not to lyse: Clinical significance of red blood cell autoantibodies
Meulenbroek, E. M., Wouters, D., & Zeerleder, S. S. (2015) · Blood Reviews · doi:10.1016/j.blre.2015.05.001 · Cited by 39
“Changes in Fc galactosylation are still an interesting concept for this autoimmune disease, since in rheumatoid arthritis also reduced galactosylation of total serum IgG was reported that can lead to more lectin pathway activation [44], however, more studies with human anti-RBC autoantibodies are required to say wheth…”
BackgroundKommineni, V., Markert, M., Ren, Z., Palle, S., Carrillo, B., Deng, J., Tejeda, A., Nandi, S., McDonald, K. A., Marcel, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010194 · Cited by 39
N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events
Hoshi, R. A., Plavša, B., Liu, Y., Trbojević‐Akmačić, I., Glynn, R. J., Ridker, P. M., Cummings, R. D., Gudelj, I., Lauc, G., Demler, O., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323623 · Cited by 39
“44,46 Therefore, current results suggest a proinflammatory activity induced by the lack of terminal galactose residues with a potential role in CVD pathophysiology.”
BackgroundSaroha, A., Kumar, S., Chatterjee, B. P., & Das, H. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046374 · Cited by 38
“These changes in glycosylation activate the immune system and lead to chronic inflammation of the synovial membrane [19].”
BackgroundProduction of Plant Made Pharmaceuticals: From Plant Host to Functional Protein
Nagels, B., Weterings, K., Callewaert, N., & Damme, E. J. M. V. (2012) · Critical Reviews in Plant Sciences · doi:10.1080/07352689.2011.616075 · Cited by 39
“A serum protein mannose-binding lectin, structurally homologous to C1q of the CDC system, can recognize and bind terminal fucose, glucose, mannose and N-acetylglucosamine.”
BackgroundInfluentialGlycans as critical regulators of gut immunity in homeostasis and disease
Dias, A. M., Pereira, M. S., Padrão, N., Alves, I., Marcos‐Pinto, R., Lago, P., & Pinho, S. S. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.007 · Cited by 38
Unmet challenges in membranous nephropathy
Salant, D. J. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000459 · Cited by 38
Immunoglobulin G glycans – Biomarkers and molecular effectors of aging
Krištić, J., Lauc, G., & Pezer, M. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.08.006 · Cited by 38
Klein, A., Carré, Y., Louvet, A., Michalski, J., & Morelle, W. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900133 · Cited by 38
“Agalactosylated IgG have modified biological properties; in vitro they activate the complementary pathway via mannose-binding lectin [44], and an enhanced Fc receptor binding [45].”
BackgroundBondt, A., Nicolardi, S., Jansen, B. C., Kuijper, T. M., Hazes, J. M. W., van der Burgt, Y. E. M., Wuhrer, M., & Dolhain, R. J. E. M. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1367-0 · Cited by 38
“Glycans may influence immunological properties of antibodies by affecting, for example, receptor binding, half-life, or binding of complement [9, 10].”
BackgroundAntibody Expression and Production
Al‐Rubeai, M. (2011) · Cell engineering · doi:10.1007/978-94-007-1257-7 · Cited by 38
Lund, J., Takahashi, N., Popplewell, A., Goodall, M., Pound, J. D., Tyler, R., King, D. J., & Jefferis, R. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01839.x · Cited by 38
Acute‐phase glycoprotein N‐glycome of ovarian cancer patients analyzed by CE‐LIF
Weiz, S., Wieczorek, M., Schwedler, C., Kaup, M., Braicu, E. I., Sehouli, J., Tauber, R., & Blanchard, V. (2016) · Electrophoresis · doi:10.1002/elps.201500518 · Cited by 37
The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation
Olivares, N., Marquina, B., Mata‐Espinosa, D., Zatarain-Barrón, Z. L., Espitia-Pinzón, C., Estrada, I., Parada, C., Collin, M., Rook, G. A. W., & Hernández‐Pando, R. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12069 · Cited by 37
“For example, an increase in GlcNAc residues produces lectin complement activation due to an increased affinity of the IgG for the ficolins in serum (Malhotra et al., 1995) and reduces CDC by decreasing the affinity of the IgG to C1q (Hodoniczky et al.”
BackgroundSialylation Determines the Nephritogenicity of IgG3 Cryoglobulins
Otani, M., Kuroki, A., Kikuchi, S., Kihara, M., Nakata, J., Ito, K., Furukawa, J., Shinohara, Y., & Izui, S. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050477 · Cited by 37
Role of collectins and complement protein C1q in pregnancy and parturition
Madhukaran, S. P., Alhamlan, F. S., Kale, K., Vatish, M., Madan, T., & Kishore, U. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.06.002 · Cited by 37
“Postpartum decrease in IgG galactosylation and MBL leads to outburst of RA disease (Malhotra et al., 1995).”
BackgroundImmunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection
Giron, L. B., Liu, Q., Adeniji, O. S., Yin, X., Kannan, T., Ding, J., Lu, D. Y., Langan, S. J., Zhang, J., Azevedo, J. L. L. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47279-4 · Cited by 38
“Conversely, IgG agalactosylation is linked to pro-in fl ammatory functions by inhibiting these cascades 14,73,74 .”
Orthogonal Technologies for NISTmAb N-Glycan Structure Elucidation and Quantitation
Prien, J. M., Stöckmann, H., Albrecht, S., Millán‐Martín, S., Varatta, M., Furtado, M., Hosselet, S., Wang, M., Formolo, T., Rudd, P. M., et al. (2015) · ACS symposium series · doi:10.1021/bk-2015-1201.ch004 · Cited by 36
Self-citationPatients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation
Sonneveld, M. E., de Haas, M., Koeleman, C. A. M., de Haan, N., Zeerleder, S. S., Ligthart, P. C., Wuhrer, M., van der Schoot, C. E., & Vidarsson, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-08654-y · Cited by 36
Association of Medication with the Human Plasma N-Glycome
Saldova, R., Huffman, J. E., Adamczyk, B., Mužinić, A., Kattla, J. J., Pučić‐Baković, M., Novokmet, M., Abrahams, J. L., Hayward, C., Rudan, I., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr2010605 · Cited by 36
Self-citationThe crystal structure of rabbit IgG-Fc
Girardi, E., Holdom, M. D., Davies, A. M., Sutton, B. J., & Beavil, A. J. (2008) · Biochemical Journal · doi:10.1042/bj20081355 · Cited by 36
Jiang, K., Zhu, H., Li, L., Guo, Y., Gashash, E. A., Ma, C., Sun, X., Li, J., Zhang, L., & Wang, P. G. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.05.029 · Cited by 36
Chapter 2 Human Total Serum N‐Glycome
(2008) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)00402-2 · Cited by 36
The Association Between Low Back Pain and Composition of IgG Glycome
Freidin, M. B., Keser, T., Gudelj, I., Štambuk, J., Vučenović, D., Allegri, M., Štambuk, T., Šimurina, M., Fabiane, S. M., Lauc, G., et al. (2016) · Scientific Reports · doi:10.1038/srep26815 · Cited by 35
“Glycans that lack terminal galactose activate complement and make IgG pro-inflammatory, while the addition of galactose decreases inflammatory potential of IgG 18,19 .”
Liu, H., Nowak, C., Andrien, B. A., Shao, M., Ponniah, G., & Neill, A. (2017) · Biotechnology Progress · doi:10.1002/btpr.2498 · Cited by 35
“The removal of the terminal galactose exposed the high mannose core and allowed the binding of mannose-binding lectin (MBL) leading to complement activation in vitro.(65,72) The current understanding is that the terminal galactose has minimal impact on ADCC, but more substantial impact on CDC.”
BackgroundDall’Olio, F. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_17 · Cited by 35
Is primary membranous nephropathy a complement mediated disease?
Reinhard, L., Stahl, R. A. K., & Hoxha, E. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.10.017 · Cited by 35
Functional analysis of agalactosyl IgG in inflammatory bowel disease patients
Nakajima, S., Iijima, H., Shinzaki, S., Egawa, S., Inoue, T., Mukai, A., Hayashi, Y., Kondo, J., Akasaka, T., Nishida, T., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21459 · Cited by 35
“in patients with RA and systemic lupus erythematosus.(17,32,33) The pathogenic role of agalactosyl IgG was further confirmed by the fact that murine collagen-induced arthritis is accelerated in the presence of agalactosyl IgG.”
BackgroundCheng, S., Xiao, B., & Luo, Z. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00506-4 · Cited by 34
Zinc supplementation decreases galactosylation of recombinant IgG in CHO cells
Prabhu, A., Gadre, R. V., & Gadgil, M. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9064-8 · Cited by 34
Perspectives in membranous nephropathy
Tomas, N. M., Huber, T. B., & Hoxha, E. (2021) · Cell and Tissue Research · doi:10.1007/s00441-021-03429-4 · Cited by 35
Glycosylation in Autoimmune Diseases
Ząbczyńska, M., Link‐Lenczowski, P., & Pocheć, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-70115-4_10 · Cited by 35
Kanoh, Y., Mashiko, T., Danbara, M., Takayama, Y., Ohtani, S., Imasaki, T., Abe, T., & Akahoshi, T. (2004) · Oncology · doi:10.1159/000079484 · Cited by 34
“showed that serum IgG oligosaccharide chains lacking galactose (Gla) (agalactosyl IgG oligosaccharide) are frequently found in the serum of rheumatoid arthritis (RA) patients. It is hypothesized that agalactosyl IgG oligosaccharide activates the complement system via mannose-binding protein, contributing to the pathog…”
BackgroundKim, Y., Kim, S., Hur, Y., Joo, H., Chung, J., Lee, D., Royle, L., Rudd, P. M., Dwek, R. A., Harvey, D. J., et al. (2006) · PROTEOMICS · doi:10.1002/pmic.200500275 · Cited by 34
Self-citationThe importance of IgG N-glycosylation in Health, Disease, and Neonatal hemochromatosis
Thaçi, K., & Anthony, R. M. (2025) · Glycoscience & Therapy · doi:10.1016/j.glycos.2025.100002 · Cited by 33
Altered expression and glycosylation of plasma proteins in rheumatoid arthritis
Raghav, S. K., Gupta, B., Agrawal, C., Saroha, A., Das, R. H., Chaturvedi, V. P., & Das, H. R. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-7922-6 · Cited by 33
“Such complexes have been recovered from the synovial fluid of RA patients [11].”
BackgroundCindrić, A., Krištić, J., Kavur, M. M., & Pezer, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-70115-4_17 · Cited by 33
Comparative analysis of transferrin and IgG N-glycosylation in two human populations
Trbojević‐Akmačić, I., Vučković, F., Pribić, T., Vilaj, M. Ć., Černigoj, U., Vidič, J., Šimunović, J., Kępka, A., Kolčić, I., Klarić, L., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04685-6 · Cited by 33
Klein, A. (2008) · PubMed · Cited by 33
Antibody‐Mediated Rejection: Emergence of Animal Models to Answer Clinical Questions
Baldwin, W. M., Valujskikh, A., & Fairchild, R. L. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03065.x · Cited by 33
“As a result, G0 autoantibodies activate complement through the lectin pathway in both humans and mice (44,45).”
BackgroundChocholova, E., Bertók, T., Jáné, E., Lorencová, L., Holazová, A., Belicka, L., Belický, Š., Mislovičová, D., Vikartovská, A., Imrich, R., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.02.031 · Cited by 33
Gupta, B., Agrawal, C., Raghav, S. K., Das, S. K., Das, R. H., Chaturvedi, V. P., & Das, H. R. (2005) · Journal of Human Genetics · doi:10.1007/s10038-005-0299-8 · Cited by 33
“According to Malhotra et al. (1995), the presence of high levels of MBL2-IgG0 complex in the synovial fluid might trigger a hyperinflammatory response, and, therefore, MBL2 deficiency may have a protective effect against RA.”
BackgroundSweet and Sour: The Role of Glycosylation for the Anti-inflammatory Activity of Immunoglobulin G
Böhm, S., Kao, D., & Nimmerjahn, F. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_18 · Cited by 32
Paoliello-Paschoalato, A. B., Marchi, L. F., de Andrade, M. F., Kabeya, L. M., Donadi, E. A., & Lucisano-Valim, Y. M. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/429878 · Cited by 32
“In RA, the complement system is activated by circulating and deposited ICs, rheumatoid factors, anti-CCP antibodies, IgG molecules with altered glycosylation patterns, C-reactive protein, and surface molecules exposed after cartilage damage [54, 59].”
BackgroundKonno, N., Sugimoto, M., Takagi, T. J., Furuya, M. Y., Asano, T., Sato, S., Kobayashi, H., Migita, K., Miura, Y., Aihara, T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196163 · Cited by 32
Metadata
- Authors
- Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B.
- Affiliations
- University of Oxford (GB)
- Venue
- Nature Medicine
- Published
- 1995-03
- Volume
- 1
- Issue
- 3
- Pages
- 237-243
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2053863608
- Cited by
- 786
- References
- 33
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 17 · 2022: 34 · 2021: 29 · 2020: 25 · 2019: 32 · 2018: 35 · 2017: 34 · 2016: 32 · 2015: 27 · 2014: 36 · 2013: 36 · 2012: 29
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- rheumatoid arthritis, IgG glycosylation, mannose-binding protein, complement activation, Fc fragment, N-acetylglucosamine, synovitis, chronic inflammation
- MeSH terms
- Arthritis, Rheumatoid, Carbohydrate Sequence, Carrier Proteins, Complement Activation, Computer Simulation, Glycosylation, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Synovial Fluid, Mannose-Binding Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.